ribavirin has been researched along with triphosphoric acid in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deval, J; Jin, Z; Kim, B; Rajwanshi, VK; Smith, LK | 1 |
| Inoue, A; Komiyama, T; Matsumura, H; Mizunuma, T; Otori, K; Tanaka, Y; Yokomori, H | 1 |
| Arbiza, J; Cancela, F; Gumbis, G; Houston, DR; Mirazo, S; Panzera, Y; Pérez, R; Quintero-Gil, C; Rendon-Marin, S | 1 |
| Bearne, SL; Gillis, TD | 1 |
4 other study(ies) available for ribavirin and triphosphoric acid
| Article | Year |
|---|---|
The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-triphosphate towards influenza A virus polymerase.
Topics: Amides; Animals; Antimetabolites; Antiviral Agents; Base Pair Mismatch; Base Pairing; DNA-Directed DNA Polymerase; Humans; Influenza A virus; Polyphosphates; Pyrazines; Ribavirin; Sf9 Cells; Spodoptera; Substrate Specificity | 2013 |
Tolerability of Erythrocyte Ribavirin Triphosphate Concentrations Depends on the ITPA Genotype.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Asian People; Erythrocytes; Female; Genotype; Hepatitis C; Humans; Inosine Triphosphatase; Male; Middle Aged; Polyphosphates; Pyrophosphatases; Ribavirin | 2019 |
Modelling of Hepatitis E virus RNA-dependent RNA polymerase genotype 3 from a chronic patient and
Topics: Antiviral Agents; Genotype; Hepatitis E; Hepatitis E virus; Humans; Molecular Docking Simulation; Ribavirin; RNA-Dependent RNA Polymerase | 2023 |
Effects of the 5'-Triphosphate Metabolites of Ribavirin, Sofosbuvir, Vidarabine, and Molnupiravir on CTP Synthase Catalysis and Filament Formation: Implications for Repurposing Antiviral Agents against SARS-CoV-2.
Topics: Antiviral Agents; COVID-19; Cytidine; Escherichia coli; Humans; Ribavirin; SARS-CoV-2; Sofosbuvir; Vidarabine | 2022 |